{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:25:54Z","timestamp":1787243154292,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Erasmus MC University Medical Centre","award":["grant no. 2015-15209"],"award-info":[{"award-number":["grant no. 2015-15209"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are differences in infection prevention and control (IPC) policies to prevent transmission of highly resistant microorganisms (HRMO). The aim of this study is to give an overview of the IPC policy of six European hospitals and their HRMO prevalence, to compare the IPC policies of these hospitals with international guidelines, and to investigate the hospitals\u2019 adherence to their own IPC policy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The participating hospitals were located in Salzburg (Austria), Vienna (Austria), Kayseri (Turkey), Piraeus (Greece), Rome (Italy) and Rotterdam (The Netherlands). Data were collected via an online survey. Questions were aimed at prevalence rates in the years 2014, 2015, 2016 of carbapenemase-producing\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (CPK), carbapenemase-producing\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (CPPA), vancomycin-resistant\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      (VRE) and hospitals\u2019 IPC policies of 2017. Implemented IPC measures (i.e. with a self-reported adherence of &gt;\u200990%) were counted (26 points maximal).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The self-reported prevalence of CPK per year was low in the Austrian and Dutch hospitals and high in the Turkish and Greek hospitals. CPPA was highly prevalent in the Turkish hospital only, while the prevalence of VRE in four hospitals, except the Austrian hospitals which reported lower prevalence numbers, was more evenly distributed. The Dutch hospital had implemented the most IPC measures (n\u2009=\u200921), the Turkish and Greek hospitals the least (n\u2009=\u200914 and 7, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hospitals with the highest self-reported prevalence of CPK and CPPA reported the least implemented IPC measures. Also, hospitals with a higher prevalence often reported a lower adherence to own IPC policy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-022-01165-0","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:06:47Z","timestamp":1670317607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Infection prevention and control policies in hospitals and prevalence of highly resistant microorganisms: an international comparative study"],"prefix":"10.1186","volume":"11","author":[{"given":"Manon D.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Voor in \u2019t holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Petrosillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Presterl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00ebtte A.","family":"Severin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet C.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ESCMID Study Group for Nosocomial Infections (ESGNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"issue":"2","key":"1165_CR1","doi-asserted-by":"publisher","first-page":"162 e1","DOI":"10.1016\/j.cmi.2015.10.001","volume":"22","author":"G Birgand","year":"2016","unstructured":"Birgand G, Moore LS, Bourigault C, Vella V, Lepelletier D, Holmes AH, et al. Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost? Clin Microbiol Infect. 2016;22(2):162 e1\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1165_CR2","unstructured":"European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2016. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017."},{"key":"1165_CR3","unstructured":"Ducel G, Fabry J, Nicolle L. Prevention of hospital-acquired infections: a practical guide. World Health Organization; 2002."},{"issue":"2","key":"1165_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1473-3099(14)70854-0","volume":"15","author":"W Zingg","year":"2015","unstructured":"Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, et al. Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis. 2015;15(2):212\u201324.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"1165_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12427","volume":"20","author":"E Tacconelli","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1\u201355.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1165_CR6","doi-asserted-by":"publisher","first-page":"e027683","DOI":"10.1136\/bmjopen-2018-027683","volume":"9","author":"E Tacconelli","year":"2019","unstructured":"Tacconelli E, Buhl M, Humphreys H, Malek V, Presterl E, Rodriguez-Bano J, et al. Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe. BMJ Open. 2019;9(5):e027683.","journal-title":"BMJ Open"},{"issue":"4","key":"1165_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/658941","volume":"32","author":"I Willemsen","year":"2011","unstructured":"Willemsen I, Elberts S, Verhulst C, Rijnsburger M, Filius M, Savelkoul P, et al. Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study). Infect Control Hosp Epidemiol. 2011;32(4):333\u201341.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"1165_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1086\/500624","volume":"27","author":"CD Salgado","year":"2006","unstructured":"Salgado CD, Farr BM. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect Control Hosp Epidemiol. 2006;27(2):116\u201321.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"1165_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1086\/502213","volume":"24","author":"CA Muto","year":"2003","unstructured":"Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003;24(5):362\u201386.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5\u20136","key":"1165_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s15010-005-5079-z","volume":"33","author":"MF Kluytmans-Vandenbergh","year":"2005","unstructured":"Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005;33(5\u20136):309\u201313.","journal-title":"Infection"},{"issue":"2","key":"1165_CR11","doi-asserted-by":"publisher","first-page":"e0148175","DOI":"10.1371\/journal.pone.0148175","volume":"11","author":"D Souverein","year":"2016","unstructured":"Souverein D, Houtman P, Euser SM, Herpers BL, Kluytmans J, Den Boer JW. Costs and Benefits Associated with the MRSA Search and Destroy Policy in a Hospital in the Region Kennemerland, The Netherlands. PLoS ONE. 2016;11(2):e0148175.","journal-title":"PLoS ONE"},{"key":"1165_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13756-016-0149-9","volume":"6","author":"J Storr","year":"2017","unstructured":"Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6:6.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1165_CR13","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2015. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2017."},{"key":"1165_CR14","unstructured":"World Health Organization. Central Asian and Eastern European Surveillance of Antimicrobial Resistance: annual report 2016. 2016. Report No.: 9289052252."},{"key":"1165_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fmicb.2019.00080","volume":"10","author":"CC Sheu","year":"2019","unstructured":"Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. Front Microbiol. 2019;10:80.","journal-title":"Front Microbiol"},{"key":"1165_CR16","doi-asserted-by":"crossref","unstructured":"Garcia-Clemente M, de la Rosa D, Maiz L, Giron R, Blanco M, Olveira C, et al. Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases. J Clin Med. 2020;9(12).","DOI":"10.3390\/jcm9123800"},{"key":"1165_CR17","unstructured":"World Health Organization. Guidelines on prevention and control of hospital associated infections. New Delhi; 2002."},{"key":"1165_CR18","volume-title":"Practical guidelines for infection control in health care facilities","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Practical guidelines for infection control in health care facilities. India: World Health Organization; 2004."},{"key":"1165_CR19","unstructured":"World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. Geneva; 2016."},{"key":"1165_CR20","unstructured":"World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumanni and Pseudomonas aeruginosa in health care facilities. Geneva; 2017."},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13756-017-0259-z","volume":"6","author":"AP Magiorakos","year":"2017","unstructured":"Magiorakos AP, Burns K, Rodriguez Bano J, Borg M, Daikos G, Dumpis U, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control. 2017;6:113.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1165_CR22","unstructured":"Nulens E. Chapter 7: Isolation of Communicable Diseases. In: Bearman G, editor. Guide to infection control in the hospital. International society for infectious diseases; 2018."},{"key":"1165_CR23","unstructured":"Centers for Disease Control and Prevention. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) - November 2015 Update CRE Toolkit.; 2015."},{"issue":"10 Suppl 2","key":"1165_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajic.2007.10.007","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Last update: May 2022. Am J Infect Control. 2007;35(10 Suppl 2):65\u2013164.","journal-title":"Am J Infect Control"},{"issue":"1","key":"1165_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13756-022-01051-9","volume":"11","author":"D Vuichard-Gysin","year":"2022","unstructured":"Vuichard-Gysin D, Sommerstein R, Kronenberg A, Buetti N, Eder M, Piezzi V, et al. High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey. Antimicrob Resist Infect Control. 2022;11(1):19.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"1165_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis"}],"updated-by":[{"DOI":"10.1186\/s13756-023-01221-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000}}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01165-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01165-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01165-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T21:12:38Z","timestamp":1680037958000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01165-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01165-0","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13756-023-01221-3","URL":"https:\/\/doi.org\/10.1186\/s13756-023-01221-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of the Erasmus MC agreed to the ethical requirements of this study and approved that the study did not fall under the Dutch law on Medical Research in Humans (non-WMO) (MEC-2015-306).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}